KMB vs NRIX · P/E 19, rev $20.06B vs rev $54.5M
Kimberly-Clark Corporation (KMB) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported KMB revenue for 2024-12-31 was $20.06B. Net income was $2.58B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the KMB and NRIX stock pages for the full models.
Not investment advice.